Cellular repopulation of human vein allograft bypass grafts

Journal of Vascular Surgery

Volumn 31, Issue 5, 2000, Pages 994-1002

  Johnson, Todd R ^a   Tomaszewski, John E ^a   Carpenter, Jeffrey P ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE;

ALLOGRAFT; ARTICLE; CELL INFILTRATION; CELL NUCLEUS MEMBRANE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM LESION; EXPLANT; FEMALE; GRAFT REJECTION; HOST CELL; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN GRAFT; VASCULAR ENDOTHELIUM; X CHROMOSOME; Y CHROMOSOME;

EID: 0034088569     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2000.105676     Document Type: Article

References (23)

1. Londrey GL, Ramsey DE, Hodgson KM, et al. Intrapopliteal bypass for severe ischemia: comparison of autogenous vein, composite, and prosthetic grafts. J Vasc Surg 1991;5:631-6.
2. Carpenter JP, Tomaszewski JE. Human saphenous vein allograft bypass grafts: Immune response. J Vasc Surg 1998;27:492-9.
3. Carpenter JP, Tomaszewski JE. Immunosuppression for human saphenous vein allograft bypass surgery: a prospective randomized trial. J Vasc Surg 1997;26:32-42.
4. Carrell A. Ultimate result of aortic transplantation. J Exp Med 1912;15:389-98.
5. Szilagyi DE, Elliot JP Jr, Smith RF, et al. A thirty-year survey of the reconstructive treatment of aortoiliac occlusive disease. J Vasc Surg 1986;3:421-36.
6. Dennis JW, Littooy FN, Greisler HP, Baker WH. Secondary vascular procedures with polytetrafluoroethylene grafts for lower-extremity ischemia in a male veteran population. J Vasc Surg 1988;8:137-42.
7. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA, et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstruction. J Vasc Surg 1986;3:104-14.
8. Ochsner JL, DeCamp PT, Leonard GL. Experience with fresh venous allografts as arterial substitute. Ann Surg 1971;173:933-9.
9. Selke FW, Meng RL, Rossi NP. Cryopreserved saphenous vein homografts for femoral-distal vascular reconstruction. J Cardiovasc Surg (Torino) 1989;30:838-42.
10. Martin RS, Edwards WH, Mulherin JL, Edwards WH, Jenkins JM, Hoff SJ. Cryopreserved saphenous vein allografts for below-knee lower extremity revascularization. Ann Surg 1994;219:664-72.
11. Shah RM, Faggioli GL, Mangione S, Harris LM, Kane J, Taheri SA, et al. Early results with cryopreserved saphenous vein allografts for infrainguinal bypass. J Vasc Surg 1993;18:965-71.
12. Harris RW, Schneider PA, Andros G, Oblath RW, Salles-Cunha S, Dulawa L. Allograft vein bypass: is it an acceptable alternative for infrapopliteal revascularization? J Vasc Surg 1993;18:553-60.
13. Walker PJ, Mitchell RS, McFadden PM, James DR, Mehigan JT. Early experience with cryopreserved saphenous vein allografts as a conduit for complex limb-salvage procedures. J Vasc Surg 1993;18:561-9.
14. Gournier JP, Favre JP, Gay JL, Barral X. Cryopreserved arterial allografts for limb salvage in the absence of suitable saphenous vein: two-year results in 20 cases. Ann Vasc Surg 1995;9(suppl):7-14.
15. Mackel AM, DeLustro F, DeLustro B, Fudenberg HH, LeRoy EC. Immune response to connective tissue components of the basement membrane (review). Connect Tissue Res 1982;10(3-4):333-43.
16. Schwartz SI, Kutner FR, Neistadt A, Barner H, Resinocoff S, Vaughan J. Antigenicity of homografted veins. Surgery 1967;61:471-7.
17. Perloff LJ, Reckard CR, Rowlands DT Jr, et al. The venous homograft: an immunological question. Surgery 1972;72:961-70.
18. Thiede A, Engemann R, Korner HH, et al. Vein replacement with fresh vital veins: a comparison of transplantation in RT-1 different rat strain combinations. Ann Surg 1981;193:283-7.
19. Axthelm SC, Porter JM, Strickland S, et al. Antigenicity of venous allografts. Ann Surg 1979;189:290-3.
20. Fugitani R, Bassiouny H, Gewertz B, Glagov S, Zarins C. Cryopreserved saphenous vein allogenic homografts: an alternative conduit in lower-extremity arterial reconstruction in infected fields. J Vasc Surg 1992;15:519-26.
21. Miller VM, Bergman T, Gloviczki P, Brockbank K. Cryopreserved venous allografts: effects of immunosuppression and platelet therapy on patency and function. J Vasc Surg 1993;18:216-26.
22. Vischjager M, Van Gulik T, Van Marle J, Pfaffendorf M, Jacobs M. Function of cryopreserved arterial allografts under immunosuppressive protection with cyclosporine A. J Vasc Surg 1996;24:876-82.
23. Elwood ET, Larsen CP, Maurer DH, Routenberg KL, Neylan JF, Whelchel JD, et al. Microchimerism and rejection in clinical transplantation. Lancet 1997;349:1358-60.